Korean Market
OWNR
Dongsung Pharmaceutical
★

UAMCO Acquires 31.5 Billion Won in Convertible Bonds of Dongsung Pharmaceutical, Raising Dilution Concerns

 
EXCH
Dongsung Pharmaceutical
★

Dongsung Pharmaceutical Appoints Experienced Pharma Executive Choi Yong-seok as New CEO

 
OTHR
Dongsung Pharmaceutical
★

Dongsung Pharmaceutical Appoints 4 Outside Directors Under Court Rehabilitation, Governance Improvement Expected

 
OWNR
Dongsung Pharmaceutical
★

TAEKWANG INDUSTRIAL Acquires 10 Million Convertible Bonds of Dongsung Pharmaceutical Ownership Ratio of Specific Securities Rises to 37.60 Percent

 
OWNR
Dongsung Pharmaceutical
★

Dongsung Pharmaceutical's largest shareholder UAMCO PEF increases stake to 81.98% via convertible bonds under rehabilitation plan, strengthening management stability

 
OWNR
Dongsung Pharmaceutical
★

IBK Financial Group-UAMCO Fund Acquires 8.5 Million Convertible Bonds of Dongsung Pharmaceutical, Increasing Potential Dilution Risk

 
FTC
Dongsung Pharmaceutical
★

Dongsung Pharmaceutical's first group status disclosure after Taekwang affiliation: 620% debt ratio and 10.1B KRW operating loss highlight need for restructuring despite rehabilitation completion

 
EXCH
Dongsung Pharmaceutical
★★★

Dongsung Pharmaceutical Corporate Governance Report: Post-rehabilitation, no dividends and many CG non-compliances raise concerns for shareholder value

 
EXCH
Dongsung Pharmaceutical
★★

Dongsung Pharmaceutical Requests Review of Improvement Plan Implementation - Corporate Review Committee to Convene by June 23, 2026

 
EXCH
Dongsung Pharmaceutical
★

Dongsung Pharmaceutical's 518,537 Shares Held by SD Energy to Be Released from Lock-up

 
MATR
Dongsung Pharmaceutical
★★

Delay in Capital Reduction Schedule Under Rehabilitation Plan, Pending Re-disclosure

 
EXCH
Dongsung Pharmaceutical
★

Cancellation of EGM Convocation Due to Conclusion of Rehabilitation

 
EXCH
Dongsung Pharmaceutical
★

Correction of Record Date Due to Cancellation of Extraordinary General Meeting

 
EXCH
Dongsung Pharmaceutical
★★★★

Decision to Close Rehabilitation Proceedings – Financial Structure Stabilization and Normalization

 
EXCH
Dongsung Pharmaceutical
★★

Lawsuit Filed for Damage Claim (Claim Amount ~₩1.68 billion, 7.2% of Equity)